Where are we going with SSRIs?

[1]  D. Stein,et al.  Paroxetine in social phobia/social anxiety disorder , 1999, British Journal of Psychiatry.

[2]  K. Brady,et al.  Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorder , 1998, European Neuropsychopharmacology.

[3]  R. Bordet,et al.  Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique. , 1998, The American journal of psychiatry.

[4]  E. Mundo,et al.  Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double blind, placedo‐controlled study , 1998, International clinical psychopharmacology.

[5]  M. Stein,et al.  Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. , 1998, JAMA.

[6]  Trevor R. Norman,et al.  Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? , 1998, European journal of pharmacology.

[7]  Tomé Mb,et al.  One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks , 1998 .

[8]  C. Reynolds,et al.  A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. , 1998, The Journal of clinical psychiatry.

[9]  J. Bigger,et al.  Cardiovascular effects of fluoxetine in depressed patients with heart disease. , 1998, The American journal of psychiatry.

[10]  M. Liebowitz,et al.  An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. , 1998, Journal of clinical psychopharmacology.

[11]  C. Katona,et al.  A double‐blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia , 1998 .

[12]  B. Pollock,et al.  Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.

[13]  E. Smeraldi,et al.  How long should pindolol be associated with paroxetine to improve the antidepressant response? , 1997, Journal of clinical psychopharmacology.

[14]  P. Dannon,et al.  P.3.013 Pindoiol augmentation in the treatment of resistant panic disorder: A double-blind placebo-controlled trial , 1997, European Neuropsychopharmacology.

[15]  A. Contu.  P.1.138 Depression in breast cancer patients — comparison of paroxetine and amitriptyline , 1997, European Neuropsychopharmacology.

[16]  B. Hunter.  P.1.056 Depression associated with rheumatoid arthritis — comparison of paroxetine and amitriptyline , 1997, European Neuropsychopharmacology.

[17]  V. Pérez,et al.  Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment , 1997, The Lancet.

[18]  P. Rocca,et al.  Paroxetine efficacy in the treatment of generalized anxiety disorder , 1997, Acta psychiatrica Scandinavica.

[19]  M. Tome,et al.  Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency , 1997, International clinical psychopharmacology.

[20]  L. Koran,et al.  Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder? , 1996, Journal of clinical psychopharmacology.

[21]  P. Blier,et al.  Sequential administration of augmentation strategies in treatment‐resistant obsessive‐compulsive disorder: preliminary findings , 1996, International clinical psychopharmacology.

[22]  R. Kessler,et al.  Posttraumatic stress disorder in the National Comorbidity Survey. , 1995, Archives of general psychiatry.

[23]  K. Brady,et al.  Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. , 1995, The Journal of clinical psychiatry.

[24]  P. Blier,et al.  Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. , 1995, Journal of clinical psychopharmacology.

[25]  D. Shera,et al.  Fluoxetine in posttraumatic stress disorder. , 1994, The Journal of clinical psychiatry.

[26]  R. Kessler,et al.  DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[27]  V. Pérez,et al.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. , 1994, Archives of general psychiatry.

[28]  N. Frasure-smith,et al.  Depression following myocardial infarction. Impact on 6-month survival. , 1993, JAMA.

[29]  C. A. Morgan,et al.  Open Prospective Trial of Fluoxetine for Posttraumatic Stress Disorder , 1993, Journal of clinical psychopharmacology.

[30]  S. Hjorth,et al.  Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study , 1993, Journal of neurochemistry.

[31]  Roberto Invernizzi,et al.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.

[32]  R. Gorlin,et al.  The nature and course of depression following myocardial infarction. , 1989, Archives of internal medicine.

[33]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[34]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[35]  C. Robert Cloninger,et al.  Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. , 1998, Psychopharmacology bulletin.

[36]  G. Burrows,et al.  Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol. , 1998, International journal of psychiatry in clinical practice.

[37]  A. Anand,et al.  Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. , 1997, The American journal of psychiatry.

[38]  B. Rothbaum,et al.  Sertraline in the treatment of rape victims with posttraumatic stress disorder. , 1996, Journal of traumatic stress.

[39]  M. D. de Boer,et al.  Fluvoxamine treatment for chronic PTSD: a pilot study. , 1992, Psychotherapy and psychosomatics.

[40]  J. Feldman,et al.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1991, American heart journal.